In addition to breast cancer, HECTD4 expression is reduced in multiple other tumor types compared with corresponding normal tissues, including glioblastoma and esophageal cancers (SI Appendix, Fig. S1 D and E). This evidence concerns the gene HECTD4 and esophageal cancer.